Company Filing History:
Years Active: 2008-2010
Title: Mojgan Aghazadeh Tabrizi: Innovator in Adenosine Receptor Antagonists
Introduction
Mojgan Aghazadeh Tabrizi is a prominent inventor based in Ferrara, Italy. She has made significant contributions to the field of pharmacology, particularly in the development of adenosine receptor antagonists. With a total of 2 patents, her work focuses on addressing various medical conditions through innovative compounds.
Latest Patents
Her latest patents include groundbreaking research on adenosine A2B receptor antagonists. The present invention provides compounds that serve as adenosine A2B receptor antagonists, which may be employed for the treatment of conditions and diseases mediated by adenosine A2B receptor activity. These conditions encompass chronic and acute inflammatory diseases, type 2 diabetes, solid tumors, and various cardiac diseases, among others. The compounds are also useful as diagnostic agents for the A2B receptor, showcasing their potential in therapeutic applications.
Career Highlights
Mojgan Aghazadeh Tabrizi is currently associated with King Pharmaceuticals Research and Development, Inc. Her work at this esteemed organization has allowed her to focus on the development of novel therapeutic agents that can significantly impact patient care.
Collaborations
Throughout her career, she has collaborated with notable colleagues, including Pier Giovanni Baraldi and Pier Andrea Borea. These collaborations have further enriched her research and contributed to the advancement of her innovative projects.
Conclusion
Mojgan Aghazadeh Tabrizi stands out as a key figure in the field of pharmacology, with her innovative work on adenosine receptor antagonists paving the way for new treatments for various diseases. Her contributions continue to influence the medical community and enhance therapeutic options for patients.